| Literature DB >> 32518655 |
Kari Nytrøen1,2,3, Katrine Rolid1,2,3, Marianne Yardley1, Lars Gullestad1,2,3.
Abstract
BACKGROUND: Little is known about the effect of exercise in young heart transplant recipients, and results on group level is lacking. This study summarizes the findings of the youngest participants in two previous randomized controlled trials.Entities:
Keywords: Cardiopulmonary exercise test; Heart transplant; High-intensity interval training; Peak oxygen consumption; Peak oxygen uptake; Rehabilitation; Young recipients
Year: 2020 PMID: 32518655 PMCID: PMC7271535 DOI: 10.1186/s13102-020-00180-1
Source DB: PubMed Journal: BMC Sports Sci Med Rehabil ISSN: 2052-1847
Baseline characteristics of the two study populations < 40 years of age
| The HITTS study ( | The TEX study ( | |||
|---|---|---|---|---|
| HIT group ( | MICT group ( | HIT group ( | Control group ( | |
| Age (years) | ||||
| Range 18–39 in both studies | 29.1 ± 7.6 | 27.8 ± 6.2 | 27.1 ± 7.6 | 28.0 ± 7.8 |
| Gender (count) | Women: 0, Men:6 | Women:5, Men:5 | Women: 3, Men: 5 | Women: 2, Men: 2 |
| Time after heart transplant at inclusion | 11 ± 2.7 (weeks) | 11 ± 1.5 (weeks) | 4.4 ± 3.3 (years) | 3.0 ± 0.0 (years) |
| Waitinglist (days) | 70 (160) | 62 (138) | ||
| Donor age (years) | 31 (35) | 31 (23) | 33 (17) | 38 (29) |
| Ischemic time (min) | 209 (206) | 214 (112) | 225 (45) † | 70 (95) † |
| Creatinine (μmol/l) | 115 (35) | 105 (60) | 91 (28) † | 77 (16) † |
| Primary diagnosis (count) | ||||
| Cardiomyopathy | 3 | 9 | 7 | 3 |
| Coronary artery disease | 1 | 0 | 0 | 0 |
| Other | 2 | 1 | 1 | 1 |
† p-value < 0.05 between groups at baseline (Mann-Whitney U -test). There were no other baseline differences between the exercise-groups
SD Standard deviation, IR Interquartile range, HIT High-intensity interval training, MICT Moderate intensity continuous training, HITTS High-intensity Interval Training in de novo heart Transplant recipients in Scandinavia, TEX Transplant EXercise
Fig. 1Illustration of the two exercise protocols: a session of (a) high-intensity interval training (HIT) and (b) moderate intensity continuous training (MICT). Legend: (This figure has previously been published in Am Heart J 2016;172:96–105. Reproduced with permission. https://www.sciencedirect.com/science/article/pii/S0002870315006286)
Fig. 2Mean change ± SE in VO2 peak between exercise groups in both trials at follow-up. Legend: A visualization of young vs. old in the TEX and the HITTS study. The bars marked with “**” or “*” means that the mean change was significant (p < 0.01, or p < 0.05) at follow-up, as presented in Tables 2 and 3
Effect of exercise in the two study populations ≥40 years of age
| The HITTS study ( | The TEX study ( | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIT group ( | MICT group ( | Mean difference between groups [95%CI] | HIT group ( | Control group ( | Mean difference between groups [95%CI] | |||||||
| Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | |||||
| Gender (count) | Women:9, Men: 22 | Women:7, Men: 24 | Women:5, men:11 | Women:4, men; 15 | ||||||||
| Time after heart transplant at inclusion | 11 ± 1.8 (weeks) | 11.2 ± 1.8 (weeks) | 4.3 ± 2.4 (years) | 4.1 ± 2.3 (years) | ||||||||
| VO2peak (ml/kg/min) | 19.0 ± 3.9 | 23.3 ± 5.5 | 20.4 ± 4.8 | 23.5 ± 6.2 | 1.2 [− 0.7, 3.1] | 0.215 | 28.0 ± 6.0 | 30.0 ± 5.6 | 28.3 ± 6.0 | 28.1 ± 6.2 | 2.2 [0.6, 3.8] | |
| %VO2exp | 53.7 ± 11.5 | 66.0 ± 14.7 | 58.0 ± 12.4 | 66.7 ± 14.5 | 3.5 [− 1.8, 8.7] | 0.190 | 86.6 ± 20.5 | 92.8 ± 18.5 | 84.2 ± 19.4 | 84.4 ± 19.4 | 6.1 [0.5, 11.6] | |
| Quadriceps muscular exercise capacity (J) | 2072 ± 816 | 2997 ± 1161 | 2560 ± 1133 | 2986 ± 1067 | 499 [65, 932] | 3070 ± 1183 | 3383 ± 1058 | 2840 ± 781 | 3022 ± 937 | 131 [− 193, 456] | 0.416 | |
| Quadriceps maximum strength (Nm) | 179 ± 74 | 228 ± 80 | 195 ± 63 | 232 ± 65 | 12 [− 14, 38] | 0.363 | 267 ± 72 | 259 ± 72 | 237 ± 68 | 225 ± 59 | 4 [−15, 22] | 0.690 |
SD Standard deviation, HITTS High-intensity Interval Training in heart Transplant recipients in Scandinavia, TEX, Transplant EXercise; HIT, high-intensity interval training; MICT, moderate intensity continuous training; %VO2exp, percentage of expected VO2 peak level according to age, J Joule, Nm Newton meter
Effect of exercise in the two study populations < 40 years of age
| The HITTS study ( | The TEX study ( | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIT group ( | MICT group ( | Mean difference between groups [95%CI] | HIT group ( | Control group ( | Mean difference between groups [95%CI] | |||||||
| Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | |||||
| VO2peak (ml/kg/min) | 22.3 ± 5.6 | 30.0 ± 8.9 | 24.0 ± 6.0 | 27.0 ± 7.7 | 4.7 [0.6, 8.8] | 27.0 ± 4.7 | 32.5 ± 4.5 | 33.0 ± 8.0 | 31.5 ± 5.1 | 7.0 [2.6, 11.3] | ||
| %VO2exp | 51.3 ± 12.9 | 69.9 ± 20.4 | 59.7 ± 13.6 | 67.5 ± 16.5 | 11 [1, 20] | 66.3 ± 9.6 | 81.2 ± 13.3 | 82.5 ± 17.6 | 79.4 ± 10.3, | 18.0 [5.9, 30.0] | ||
| O2 pulse | 13.0 ± 3.0 | 15.4 ± 3.3 | 12.0 ± 2.6 | 11.7 ± 2.9 | 2.7 [− 0.1, 5.6] | 0.060 | 15.1 ± 3.7 | 16.3 ± 2.8 | 16.7 ± 5.3 | 16.6 ± 4.3 | 1.4 [− 0.5, 3.2] | 0.132 |
| HR rest echo | 91 ± 8 | 91 ± 10 | 83 ± 7 | 91 ± 8 | 8 [0, 17] | 0.053 | 85 ± 16 | 80 ± 12 | 75 ± 12 | 84 ± 17 | − 14 [− 22, − 6] | |
| HR peak | 127 (29) | 161 (43) | 136 (39) | 166 (30) | 0.064† | 156 ± 15 | 165 ± 17 | 163 ± 16 | 165 ± 18 | 7 [− 8, 15] | 0.073 | |
| %HR max | 68 ± 6 | 81 ± 8 | 69 ± 11 | 84 ± 11 | 1 [− 7, 9] | 0.731 | 81 ± 7 | 86 ± 8 | 85 ± 11 | 87 ± 10 | 4 [− 1, 8] | 0.085 |
| Chronotropic response index | 0.38 ± 0.12 | 0.63 ± 0.20 | 0.47 ± 0.17 | 0.70 ± 0.24 | 0.02 [− 0.15, 0.19] | 0.770 | 0.67 ± 0.11 | 0.77 ± 0.12 | 0.77 ± 0.14 | 0.77 ± 0.16 | 0.09 [0.01, 0.17] | |
| HR recovery 2 min (bpm) | −2 ± 3 | −14 ± 12 | −3 ± 2 | − 23 ± 10 | −9 [− 21, 3] | 0.141 | − 22 ± 5 | −30 ± 6 | − 39 ± 5 | − 38 ± 10 | − 8 [− 17, 0] | 0.069 |
| Quadriceps muscular exercise capacity (J) | 2944 (3017) | 3284 (2961) | 1649 (1774) | 2524 (2824) | 0.162† | 2813 ± 2042 | 3572 ± 1598, | 3605 ± 1675 | 3697 ± 1138 | 667 [− 382, 1716] | 0.187 | |
| Quadriceps maximum strength (Nm) | 216 (124) | 288 (136) | 172 (143) | 201 (175) | 240 ± 117 | 264 ± 111 | 279 ± 90 | 262 ± 83 | 41 [5, 77] | |||
| BMI | 23.5 ± 4.4 | 24.6 ± 4.9 | 23.2 ± 4.4 | 24.1 ± 4.9 | 0.2 [− 1.9, 2.2] | 0.858 | 27.4 ± 5.1 | 25.8 ± 4.6 | 25.7 ± 3.5 | 25.4 ± 2.3 | − 1.2 [− 4.4, 1.9] | 0.410 |
† Mann Whitney U-test
SD Standard deviation, IR Interquartile range, HITTS High-intensity Interval Training in heart Transplant recipients in Scandinavia, TEX Transplant EXercise, HIT High-intensity interval training, MICT Moderate intensity continuous training; %VO2exp, percentage of expected VO2 peak level according to age; HR Heart rate; %HR max, percentage of maximum HR according to age; J Joule, Nm Newton meter
Fig. 3Mean change ± SE in extensors’ maximum strength between exercise-groups in both trials at follow-up. Legend: A visualization of young vs. old in the TEX and the HITTS study. The bars marked with “**” or “*” means that the mean change was significant (p < 0.01, or p < 0.05) at follow-up, as presented in Tables 2 and 3
Fig. 4Mean change ± SE in extensors’ muscular exercise capacity between exercise-groups in both trials at follow-up. Legend: A visualization of young vs. old in the TEX and the HITTS study. The bars marked with “**” or “*” means that the mean change was significant (p < 0.01, or p < 0.05) at follow-up, as presented in Tables 2 and 3